Affordable access to essential medication in developing countries: conflicts between ethical and economic imperatives

Area of Science:

• Global Health
• Public Health Policy
• Pharmaceutical Economics

Background:

• Rising Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) rates threaten economic and political progress in Africa and Southeast Asia.
• Lack of affordable access to essential HIV/AIDS medications hinders effective treatment and disease management.
• Existing solutions like price cuts and drug donations are insufficient to address the crisis.

Purpose of the Study:

• To analyze the ethical frameworks surrounding access to essential HIV/AIDS medications.
• To evaluate proposed solutions for improving medication accessibility.
• To advocate for compulsory licensing as the most effective strategy.

Main Methods:

• Ethical analysis of relevant frameworks.
• Review of proposed solutions for medication access.
• Consequentialist argument for compulsory licensing.

Main Results:

• Current frameworks and solutions inadequately address the affordability crisis for essential HIV/AIDS drugs.
• Compulsory licensing presents a viable and ethically justifiable alternative.
• Economic and pragmatic benefits of compulsory licensing outweigh alternatives.

Conclusions:

• Compulsory licensing of essential HIV/AIDS medications is recommended during public health emergencies.
• This policy offers a more effective and equitable solution compared to price reductions and donation schemes.
• Implementing compulsory licensing can improve health outcomes and support development in affected regions.